| P50 | author | European Food Safety Authority | Q516521 |
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| | Oxidative Decay of DNA | Q22066181 |
| | Application of benzo(a)pyrene and coal tar tumor dose-response data to a modified benchmark dose method of guideline development | Q24815801 |
| | Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays | Q24816878 |
| | Genetic instabilities in human cancers | Q28131826 |
| | Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells | Q28143014 |
| | Ranking possible carcinogenic hazards | Q39769822 |
| | Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity | Q42163613 |
| | Aphidicolin and bleomycin induced chromosome damage as biomarker of mutagen sensitivity: a twin study | Q42456548 |
| | Associations between common polymorphisms in TP53 and p21WAF1/Cip1 and phenotypic features of breast cancer | Q43901544 |
| | Nutritional modulation of DNA repair in a human intervention study | Q44381261 |
| | Biomarkers of dietary intake of micronutrients modulate DNA adduct levels in healthy adults | Q44427335 |
| | Symposium overview: genetic polymorphisms in DNA repair and cancer risk | Q46345562 |
| | Molecular and cellular mechanisms associated with pulse-carcinogenesis in the rat nerbous system by ethyinitrosourea: ethylation of nucleic acids and elimination rates of ethylated bases from the DNA of different tissues | Q48605731 |
| | T25: a simplified carcinogenic potency index: description of the system and study of correlations between carcinogenic potency and species/site specificity and mutagenicity | Q50134105 |
| | Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? | Q50160917 |
| | Thresholds in chemical carcinogenesis. | Q52321753 |
| | Comparison of the EU T25 single point estimate method with benchmark dose response modeling for estimating potency of carcinogens. | Q52935961 |
| | Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. | Q53391983 |
| | Rodent carcinogens: setting priorities | Q53486868 |
| | Dose-response relationship and low dose extrapolation in chemical carcinogenesis. | Q53505977 |
| | In reply: carcinogenic risk estimation. | Q53522221 |
| | Calculation of carcinogenic potency from long-term animal carcinogenesis experiments. | Q53553612 |
| | Cyclin D1 gene polymorphism and susceptibility to lung cancer in a Chinese population. | Q54767981 |
| | Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. | Q30341724 |
| | A carcinogenic potency database of the standardized results of animal bioassays | Q30498518 |
| | Genome changes and gene expression in human solid tumors | Q30841588 |
| | The refinement of uncertainty/safety factors in risk assessment by the incorporation of data on toxicokinetic variability in humans | Q30986105 |
| | A comprehensive approach for integration of toxicity and cancer risk assessments | Q33537456 |
| | Polymorphisms of xenobiotic-metabolizing enzymes and susceptibility to cancer | Q33608783 |
| | p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer | Q33750337 |
| | Concepts of threshold in mutagenesis and carcinogenesis | Q33816067 |
| | Significance of multiple mutations in cancer | Q33846180 |
| | Cancer risk and low-penetrance susceptibility genes in gene-environment interactions | Q33928276 |
| | Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review | Q33936434 |
| | Biological indicators of genotoxic risk and metabolic polymorphisms | Q34053171 |
| | The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk | Q34124392 |
| | Risk characterisation of chemicals in food and diet | Q34218408 |
| | Hazard characterisation of chemicals in food and diet. dose response, mechanisms and extrapolation issues | Q34563180 |
| | Mathematical modelling and quantitative methods | Q34563187 |
| | Assessment of intake from the diet | Q34563195 |
| | Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? | Q34564801 |
| | Molecular epidemiology in environmental health: the potential of tumor suppressor gene p53 as a biomarker | Q34639833 |
| | Chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1982. | Q34659855 |
| | Second chronological supplement to the Carcinogenic Potency Database: standardized results of animal bioassays published through December 1984 and by the National Toxicology Program through May 1986. | Q34660367 |
| | Sixth plot of the carcinogenic potency database: results of animal bioassays published in the General Literature 1989 to 1990 and by the National Toxicology Program 1990 to 1993. | Q34834249 |
| | The fifth plot of the Carcinogenic Potency Database: results of animal bioassays published in the general literature through 1988 and by the National Toxicology Program through 1989. | Q34843362 |
| | Summary of carcinogenic potency and positivity for 492 rodent carcinogens in the carcinogenic potency database | Q35032800 |
| | Third chronological supplement to the carcinogenic potency database: standardized results of animal bioassays published through December 1986 and by the National Toxicology Program through June 1987. | Q35032972 |
| | The Carcinogenic Potency Database: analyses of 4000 chronic animal cancer experiments published in the general literature and by the U.S. National Cancer Institute/National Toxicology Program | Q35034775 |
| | Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes | Q35114513 |
| | Genomic instability and cancer: networks involved in response to DNA damage | Q36185744 |
| | O4-ethyldeoxythymidine, but not O6-ethyldeoxyguanosine, accumulates in hepatocyte DNA of rats exposed continuously to diethylnitrosamine | Q36255316 |
| | Molecular themes in oncogenesis | Q37625792 |
| | Cell proliferation in carcinogenesis | Q37951208 |
| | XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ | Q38298525 |
| | Hormesis--the stimulation of growth by low levels of inhibitors | Q38579123 |
| | Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes | Q39118556 |
| | Properties and assay of mammalian O6-alkylguanine-DNA alkyltransferase | Q39681347 |
| P433 | issue | 10 | |
| P921 | main subject | genotoxicity | Q1009245 |
| P304 | page(s) | 282 | |
| P577 | publication date | 2005-10-01 | |
| P1433 | published in | EFSA Journal | Q56298557 |
| P1476 | title | Opinion of the Scientific Committee on a request from EFSA related to A Harmonised Approach for Risk Assessment of Substances Which are both Genotoxic and Carcinogenic | |
| P478 | volume | 3 | |